Clinical Trials
AUS-NET – Neuroendocrine Tumours
To improve patient quality of life and develop a cost-effective system that can be implemented across other rare cancers in the future.
Clinical Engagement
Collaborate with NeuroEndocrine Cancer Australia to improve patient outcomes through research, clinical partnerships, and shared expertise.
Explore opportunities to engage in trials, contribute data, and advance neuroendocrine cancer care across Australia.
Clinical Trials
Stay informed on current clinical trials advancing neuroendocrine cancer treatment and care.
Clinical Trials
Compose GEP-NET Phase III Trial
A phase III clinical trial investigating a new treatment option for advanced neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NETs)
Clinical Trials
ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers
This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Clinical Trials
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)
PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Clinical Trials
Phase 3 Trial of CAM2029 vs Standard Treatments in GEP-NET Patients
The purpose of this study is to compare the effectiveness and safety of CAM2029 to octreotide LAR or lanreotide ATG in patients with advanced, well-differentiated GEP-NET.
PLANET Registry
Join Australia’s Neuroendocrine Cancer registry to support research and improve clinical outcomes nationwide.
Neuorendocrine Cancer Specialist Registry
View NET specialists by state, or register to be part of our specialist directory.
Helpful Resources
Booklets & Guides
About NETs
Clinical Trials
AUS-NET – Neuroendocrine Tumours
To improve patient quality of life and develop a cost-effective system that can be implemented across other rare cancers in the future.
Booklets & Guides
Basic Testing sheet for GastroEnteroPancreatic (GEP) Neuroendocrine Tumors (NETs)
Getting Diagnosed
Breaking Down the Latest NET Data: What Research Grants Are Revealing About Early Detection
Clinical Trials
Compose GEP-NET Phase III Trial
A phase III clinical trial investigating a new treatment option for advanced neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NETs)
Treatment Options
Emerging Immunotherapies for NETs
Getting Diagnosed
Genomic Profiling in Neuroendocrine Cancer
Causes & Risk Factors
Hereditary Factors in Neuroendocrine Tumours: Genetics, Risks, and Testing
Educational Videos
Lets Talk About Nuclear Medicine 27 April 2022
Treatment Options
